BMI View: The delivery of healthcare in Singapore will continue to change as the country looks to deepen
the integration of technology with its medical sector. This will see a shift in the flow of patients seeking
medical services, their interaction with physicians an ..."
BMI View: Prospects for Singapore's healthcare sector will be robust. Supported by the government's
consistent investments into the sector, the country has developed a strong research foundation which will in
turn serve to augment Singapore's competitive edge in clini ..."
BMI View: Non-communicable disease will continue to dominate Singapore's epidemiological profile,
creating strong commercial opportunities for medicines addressing these illnesses. Companies seeking to
benefit from these revenue earning prospects will have to compete ..."
BMI View: Despite the small size of the Singaporean pharmaceutical market, the country's consistent drive
into R&D, strong government commitment towards healthcare provision and its ageing population continue
to present significant commercial opportunities for pharmac ..."
BMI View: Singapore's healthcare system will continue to evolve, led by changes from the
government. This is reflected in the distinct shift in policy that will see the authorities raising its
contribution to the country's total healthcare spending. In addition, Singa ..."
BMI View: Singapore will remain a highly attractive manufacturing base for international pharmaceutical
companies due to minimal levels of operational risks and the government's support for the industry. The
pharmaceutical industry has been a key pillar of the country ..."
BMI View: Driven by a rapidly ageing population and growing government health expenditure,
Singapore's pharmaceutical sales will continue its steady growth over the next decade. This growth is only
constrained by its small population. The country's high levels of education, str ..."
BMI View: While Singapore's small population will limit the pharmaceutical market's overall growth
potential, the government's commitment to healthcare as well as the ageing population will boost
consumption of pharmaceuticals over the long term. In addition, the impe ..."
BMI View: The considerable increase in the government's healthcare expenditure highlights Singapore's
commitment to provide better, more affordable healthcare services for its population, particularly the
elderly. The government's aim to further increase its expenditu ..."
This is 2nd edition report on Singapore Medical Tourism by Renub Research. The report titled ""Singapore Medical Tourism Analysis and Forecast” provides a comprehensive analysis of the Singapore medical tourism market covering in detail various aspects of medical tourists’ arriva ..."